Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2014-15 | Page 21

### 29. Other Income

Amount in Taka

| Particulars | Note | 2015 | 2014 |
|---|---|---|---|
| Interest on FDR & Short term Investment | | 304,321,405 | 489,970,647 |
| Dividend Income | | 1,427,955 | 1,427,955 |
| Royalty | | 10,634,016 | 24,763,177 |
| Exchange Rate Fluctuation Gain / (Loss) | | (5,786,387) | 1,452,991 |
| Profit on Sale of Fixed Assets (Note 35) | | 1,081,337 | 3,556,877 |
| **Total** | | **311,678,326** | **521,171,647** |

### 30. Finance Cost

Amount in Taka

| Particulars | Note | 2015 | 2014 |
|---|---|---|---|
| Interest on Working Capital Loan | | 421,760,709 | 391,510,508 |
| Interest on Project / Consortium Loan | | 117,768,471 | 175,227,715 |
| Interest on Lease Finance | | 78,534,547 | 64,812,955 |
| Interest on Loan from PF, WPPF & Welfare Fund | | 61,102,975 | 71,225,739 |
| Other Bank Charges | | 29,803,532 | 21,538,046 |
| **Total** | | **708,970,234** | **724,314,963** |

### 31. Contribution To WPPF & Welfare Funds

This represents statutory contribution by the company as per Bangladesh Labour Act (amendment) 2013. The amount is computed @ 5% of net profit before tax (but after charging such contribution).

### 32. Income Tax Expenses

This consists of as follows :

Amount in Taka

| Particulars | Note | 2015 | 2014 |
|---|---|---|---|
| **(a) Current Tax** | | | |
| (i) Tax provision for current year (Note 3.9) | | 455,880,060 | 421,487,672 |
| (ii) Short / (excess) provision for earlier year | | (29,913,148) | 15,295,172 |
| **Subtotal** | | **425,966,912** | **436,782,844** |
| **(b) Deferred Tax Expense/(Income)- (Note 3.9)** | | **(43,121,365)** | **144,475,316** |
| **Total** | | **382,845,547** | **581,258,160** |

### 33. Earnings Per Share (EPS)

Amount in Taka

| Particulars | Note | 2015 | 2014 |
|---|---|---|---|
| (a) Earnings attributable to the Ordinary Shareholders (Tk.) | | 1,954,284,516 | 1,528,297,573 |
| (b) Weighted average number of Ordinary Shares outstanding during the year (Note 3.15) (Nos.) | | 386,244,234 | 386,244,234 |
| **Earnings Per Share (EPS) / Adjusted EPS (2014) (Tk.)** | | **5.06** | **3.96** |